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Gliomas are brain tumours that differ from most other cancers by their diffuse invasion of the surrounding normal tissue and
their notorious recurrence following all forms of therapy. We have developed a mathematical model to quantify the spatio-
temporal growth and invasion of gliomas in three dimensions throughout a virtual human brain. The model quantiﬁes the
extent of tumorous invasion of individual gliomas in three-dimensions to a degree beyond the limits of present medical
imaging, including even microscopy, and makes clear why current therapies based on existing imaging techniques are
inadequate and cannot be otherwise without other methods for detecting tumour cells in the brain. The model’s estimate of
the extent of tumourous invasion beyond that deﬁned by standard medical imaging can be useful in more accurately planning
therapy regimes as well as predicting sites of potential recurrence without waiting for reemergence on follow-up imaging.
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Gliomas are brain tumours that differ from most other tumours by
their aggressive diffuse invasion of the surrounding normal tissue.
This invasive nature contributes to their dismal 6 to 12 month
prognosis (Silbergeld et al, 1991). The remarkable continuing
development of medical imaging has increased the detection of
gliomas but has not been able to sufﬁciently deﬁne the degree of
diffuse invasion of the tumour cells peripheral to the bulk of the
tumour mass to allow for adequate assessment and treatment.
Thus, it is not surprising that even extensive surgical resection or
local irradiation of gliomas is followed by tumourous recurrence
at or near the edge of the resection bed (Gaspar et al, 1992; Liang
and Weil, 1998).
Mathematical modelling of biomedical phenomena (Murray,
1993) can be extremely helpful in analyzing factors that may
contribute to the complexity intrinsic in insufﬁciently understood
developmental processes and diseases. Despite the complexity of
gliomas some of the basic components of this disease have been
illuminated. Based on present knowledge of the properties of glio-
mas, we have developed a mathematical model to quantify the
spatio-temporal proliferation and invasion dynamics of gliomas
within anatomically accurate heterogeneous brain tissue in three
spatial dimensions. The implications of this type of modelling
would be of considerable interest to not only neuro-oncologists
attempting to improve the treatment of gliomas but also to those
interested in the quantitative study of other diseases for which
medical imaging plays a large part of the assessment of the disease
(e.g. other cancers as well as developmental diseases).
There are, of course, many properties of gliomas, but we
believe that these can be grouped together yeilding two key para-
meters: net proliferation rate and migration rate of cells. Previous
models based on these assumptions have studied the interaction
of these two characteristics of gliomas with considerable success
(Cruywagen et al, 1995; Tracqui et al, 1995; Woodward et al,
1996; Burgess et al, 1997). These previous mathematical models
of gliomas considered the brain to be a two-dimensional homoge-
neous tissue bounded only by the ventricles and skull (dura or
arachnoid) (Cruywagen et al, 1995; Tracqui et al, 1995; Wood-
ward et al, 1996; Burgess et al, 1997). Even with this anatomic
simplicity, the models could predict the behaviour of untreated
high-, intermediate- or low-grade gliomas (deﬁned by differences
in the motility and proliferation rates) (Woodward et al, 1996).
Even more interestingly, the previous models could predict the
behaviour of surgically treated high-grade gliomas to a degree of
accuracy not attainable in vivo with ‘statistically signiﬁcant prob-
ability’ even with groups of over 50 real patients (Kreth et al,
1993).
Our interest is in the transfer of these predictions from groups
of virtual patients to individual patient cases. To facilitate this, it
was necessary for our model to reﬂect both the gross and micro-
scopic anatomic complexity of the human brain. The availability
of the BrainWeb (Collins et al, 1998) brain atlas database (http://
www.bic.mni.mcgill.ca/brainweb) has allowed us to reﬁne the gross
anatomic boundaries of the human brain in three-dimensions. By
deﬁning a virtual human brain with the anatomical distribution
of grey and white matter (the two primary tissue components of
the brain) to a voxel resolution of 1 mm
3, we can model the differ-
ential motility of glioma cells in grey and white matter to
accommodate reports (Giese et al, 1996) that such differences are
biologically signiﬁcant. Speciﬁcally, since glioma cells are reported
to migrate more rapidly in white matter than in grey matter (Giese
et al, 1996; Silbergeld and Chicoine, 1997; Swanson, 1999) we allow
the motility coefﬁcient to differ depending on the local tissue
composition.
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The mathematical model
Our mathematical model for glioma growth and invasion quantify-
ing the differential motility of gliomas in grey and white matter can
be written, in words, as:
the rate of change of the tumour cell population density =
the diffusion (motility) of the tumour cells in grey and white
matter + the net proliferation of the tumour cells
and can be quantiﬁed mathematically as:
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where c(x,t) is the concentration of tumour cells at location x and
time t. D(x), a function of position x in the brain, is the diffusion
coefﬁcient deﬁning the random motility of the glioma cells with
D(x)=Dg,D w, constants for x in grey and white matter, respec-
tively. r represents the net proliferation rate of the glioma cells
and ! is the spatial differentiation operator (in effect a gradient).
As is observed biologically, the diffusion (motility) coefﬁcient in
white matter is larger than that in grey, that is, Dw 4Dg. The
difference in the diffusion coefﬁcients in grey and white matter
has been estimated to range from 2–100-fold (Swanson, 1999),
but we have chosen 5 as an arbitrary ﬁrst approximation to illus-
trate the model’s potential. To complete the model formulation, we
impose a ‘zero-ﬂux’ of cells across the brain boundaries deﬁned by
cerebrospinal ﬂuid in the ventricular and subarachnoid space. This
boundary condition simply requires that glioma cells are not
allowed to migrate outside of the brain tissue. We also assume that
the tumour has grown to about 4000 cells as a local mass before it
begins to diffuse (and the model equation (1) applies) in order to
avoid simulating a case of gliomatosis cerebri for which tumour
cells have invaded throughout the brain without a single dominant
tumour mass.
Deﬁnition of anatomic landmarks in 3-dimensions
Previous models (Cruywagen et al, 1995; Tracqui et al, 1995;
Woodward et al, 1996; Burgess et al, 1997) considered the brain
to be homogeneous, bounded only externally by the skull and
internally by the ventricles. With the BrainWeb atlas we have been
able not only to reﬁne the external boundaries to the complex sulci
(hills and valleys of the human brain cortex) to a voxel resolution
of 1 mm
3, but also to allow the virtual glioma to grow and migrate
within a true 3-dimensional representation of the human brain
allowing each 1 mm thick slice of brain to interact with grey and
white matter in adjacent planes. As for the spread of gliomas across
sulci we have no speciﬁc information as to how difﬁcult it is for
glioma cells to cross that barrier. We know that it can occur in
vivo. We suspect that it is considerably more resistant than the
boundary between grey and white matter (where we have assumed
a factor of 5 difference in motility). We have assumed, for the
purpose of the present demonstrations, that the sulci (pial) barrier
is absolute, but this is extreme and could easily be revised as more
information becomes available.
Parameter estimation
Essential to successful modelling is the ability to determine reason-
able estimates of the critical parameters, the growth rate r and the
average diffusion coefﬁcient D (an average of the diffusion coefﬁ-
cients in white matter Dw and grey matter Dg ). For high-grade
gliomas (glioblastomas) previous reports, based on extant data,
have suggested a net proliferation rate of r&0.012/day (Alvord
and Shaw, 1991; Swanson, 1999; Swanson et al, 2000), correspond-
ing to a volume-doubling time of 60 days, and a diffusion
coefﬁcient of D&0.0013 cm
2 day
71 (Swanson, 1999; Swanson et
al, 2000). The actual ranges of these values are quite extreme but
real values for any actual patient could be substituted. Variation
of the proliferation rate and diffusion coefﬁcient by 50% has been
previously shown to reproduce the survival curves observed for
high-grade gliomas (Woodward et al, 1996). We discuss elsewhere
means of calculating these parameter estimates by the use of stan-
dard imaging data for individual patients (Swanson et al,
submitted). To calculate the parameters r and D, we look to the
medical images necessary for the diagnosis of gliomas.
Thresholds of detection
For every medical imaging technique, be it CT, MRI, gross or
microscopic studies, there is a threshold of detection below which
glioma cells are not detectable. Clearly, CT and MRI have a higher
capability for detection of gliomas than gross examination of an
autopsy specimen but even microscopy has a limit beyond which
individual cells cannot be detected. For example, close to the
extreme, imagine a low concentration of tumour cells of the order
of 1 cell in a pin-head mass of tissue, about 1 mm
3. Simple arith-
metic calculations show that at a concentration of 1 cell mm
73 it
would require 100 serial sections each 10 mm thick to detect this
single cell, assuming that the cell could even be recognized by
any speciﬁc histologic technique. Conﬁrmation of this analogy
has been provided by Silbergeld and Chicoine (1997), who were
able to grow in culture glioma cells from brain tissue that was
histologically normal 4 cm distal to the gross edge of the tumour.
Furthermore, Kelly et al. (1987) were able to show in at least half
of their patients that ‘isolated tumour cells’ could be identiﬁed
microscopically in biopsies distal to even the most sensitive MRI
marker.
Previous reports (Burgess et al, 1997) estimated the enhanced
CT-delineated tumour boundary to correspond to a tumour cell
concentration of about 8000 cells mm
73. We retain this estimate,
which corresponds to about 400 cells in a low power (106 objec-
tive) microscopic ﬁeld of about 1 mm
2 or about 25 cells in a high
power (406 objective) ﬁeld.
Survival time
Previous models assumed that diagnosis is made when the volume
of an enhanced CT-detectable tumour has reached a size equivalent
to a sphere with an average 3 cm diameter and that death occurs
when the volume reaches an average 6 cm diameter. The difference
between these two times can be deﬁned as the survival time of the
hypothetical or virtual patient. With earlier even simpler models,
the comparison of calculated survival times (Woodward et al,
1996) with extant data (Kreth et al, 1993) was very good.
RESULTS
Virtual gliomas
Figure 1 shows three perpendicular cross-sections (coronal, sagittal
and horizontal or axial) of the virtual human brain intersecting in
the white matter of the brain marked by an asterisk in the superior
frontal region where the virtual tumour originates. The grey and
white matters of the brain domain appear grey and white, respec-
tively. A contour plot of the tumour cell density is represented in
colour with red denoting a high density and blue denoting a low
density. In each image, a single thick black curve deﬁnes the edge
of the tumour that the model suggests would be detectable on
enhanced CT associated with a threshold of detection of
8000 cells mm
73. The outermost light blue proﬁle corresponds
to an arbitrary threshold of detection 80 times more sensitive than
enhanced CT (i.e. 100 cells mm
73). The left column of images in
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ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(1), 14–18Figure 1 represents the tumour at the time of detection, deﬁned as
an enhanced CT-detectable tumour with average diameter of 3 cm,
while the right column represents the tumour at the time of death,
deﬁned by an enhanced CT-detectable tumour with average
diameter of 6 cm. The model predicts that there are approximately
158 days between diagnosis and death for a virtual patient with a
glioblastoma deﬁned by the given parameter estimates in this loca-
tion in the frontal lobe.
Figure 2 shows a simulation similar to that presented in Figure 1
but the virtual tumour originates at a point (asterisk) in the deep
grey matter of the thalamic region of the brain. These sites were
chosen as two of the most commonly observed in patients in
whom CT and MRI observations were correlated with histologic
ﬁndings. The model predicts that there are approximately 256 days
between diagnosis and death for a virtual patient with a glioblasto-
ma deﬁned by the given parameter estimates in this location in the
thalamus.
Note the signiﬁcant difference in survival times predicted for
these two tumours. Previous two-dimensional models have
suggested that tumour location can have a signiﬁcant impact on
survival time based simply on the local invasion abilities of the
tumour (Swanson, 1999; Swanson et al, 2000).
Figure 3 shows the survival times (time between diagnosis at
3 cm diameter and death at 6 cm diameter) predicted by the
model for a range of values of the ratio of the tumour cell migra-
tion rate in white matter to that in grey matter (g=D w/Dg). In
order to compare across different virtual cases, the ratio g is
allowed vary such that the average diffusion coefﬁcient over the
entire brain is constant at 0.0013 cm
2 day
71, the typical motility
of a high grade glioma. To maintain this relationship we use the
formula:
Average motility coefﬁcient for entire brain = Motility coefﬁ-
cient in white matter 6 Volume fraction of brain that is white
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Figure 1 Sections of the virtual human brain in sagittal, coronal and hor-
izontal planes that intersect at the site of the glioma originating in the super-
ior frontal region denoted by an asterisk (*). The left column of brain
sections corresponds to the tumour at diagnosis whereas the right column
represents the same tumour at death. Red denotes a high density of tu-
mour cells while blue denotes a low density. A thick black contour deﬁnes
the edge of the tumour detectable by enhanced CT. Cell migration was al-
lowed to occur in a truly three-dimensional solid representation of the
brain. The elapsed time between diagnosis and death for this virtual glioma
is approximately 158 days.
Diagnosis Death
Figure 2 Sections of the virtual human brain in sagittal, coronal and hor-
izontal planes that intersect at the site of the glioma originating in the tha-
lamus denoted by an asterisk (*). The left column of brain sections
corresponds to the tumour at diagnosis whereas the right column repre-
sents the same tumour at death. Red denotes a high density of tumour cells
while blue denotes a low density. A thick black contour deﬁnes the edge of
the tumour detectable by enhanced CT. Cell migration was allowed to oc-
cur in a truly three-dimensional solid representation of the brain. The
elapsed time between diagnosis and death for this virtual gliomas is ap-
proximately 256 days.
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Figure 3 The effects of on survival times of ﬁve-fold variations of the
ratio of motility in grey matter to that in white matter (g=Dw/Dg) for virtual
gliomas in frontal white matter or in thalamus.
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brain that is grey matter
Or, equivalently,
0.0013 cm
2 day
71=0.57236Dg+0.42776Dw
Recalling that Dw=gDg, then for each value of the ratio g, we have
Dg= 0.0013/(0.5723+0.4277 g)
The volume fractions of grey and white matter were extracted from
the BrainWeb database as 0.5723 and 0.4277, respectively (Collins
et al, 1998).
In Figure 3, we note that the thalamic tumour consistently is
predicted to take longer to become of fatal size. This relates to
the relatively slow rate at which the tumour cells migrate in the
deep grey matter in and around the thalamus whereas the frontal
lesion would be expected to migrate g-fold more quickly within
the local white matter. There are no data to support or refute this
difference in survival for thalamic tumours versus frontal white
matter lesions. Due to the biological eloquence of the tissue within
and in the region of the thalamus, one might expect these tumours
to behave differently in terms of clinical symptoms resulting in
perhaps a smaller size at diagnosis as well as at death. The simula-
tion results we have tabulated here do not consider the degrees of
eloquence of the brain tissue but simply track the progression of
the growth of the lesion from a typical diagnostic size of 3 cm
in diameter to a typical fatal size of 6 cm in diameter.
DISCUSSION
What is abundantly clear from the ﬁgures is how far tumour cells
have diffused beyond any current range of detection. Previous
studies of the motility of gliomas have demonstrated that diffusion
is an accurate estimation for the spread of gliomas (Woodward et
al, 1996; Swanson, 1999). A consequence of modeling cellular
motility by Fickian or gradient-driven diffusion, is the lack of a
deﬁnitive interface between malignant and normal tissue. This
mathematical consequence is correlated with the actual biology of
human gliomas. Consider using CT or MRI images to delineate
the possible interface between cancerous and normal tissue. Radical
resection of the tumour even well beyond these interfaces has been
shown to fail in numerous studies, as summarized by Nazzaro and
Neuwelt (1990). Clearly, tumour cells invade peripheral to the CT-
or MRI-deﬁned boundaries of the tumour. Even standard histo-
pathological analysis, one of our most sensitive means of
detecting glioma cells, fails in locating all of the tumour cells, as
was demonstrated by Silbergeld and Chicoine (1997).
Figures 1 and 2 show the spatio-temporal invasion of virtual
gliomas at the time of diagnosis and death. These simulations
clearly reveal the subthreshold invasion of the tumour well beyond
the detectable portion of the tumour. No matter the extent of
resection, the mathematical model indicates that the gross tumour
will ultimately recur and kill.
Resection and other localized treatment methods
Matsukado et al. (1961) analyzed 100 autopsy specimens of
supratentorial glioblastomas searching for clues that might favour
successful resection. They reported that 53 cases appeared grossly
and microscopically conﬁned to one cerebral hemisphere, 36 of
these limited to the cerebral cortex and white matter and 17
invading the basal ganglia, internal capsule or diencephalon. Of
the other cases, 25 crossed the midline, 15 of these also invading
the contralateral basal ganglia and deep nuclei. They, of course,
did not consider the hypothesis that drove the development of
our mathematical models nearly 40 years later, namely that the
two most important factors deﬁning the pattern of glioblastomas
are the growth rate and the diffusion coefﬁcient. Considered in
the present light, however, the patterns of their lobar and multi-
lobar cases suggest that the major signiﬁcant difference is the
diffusion coefﬁcient: low in those that remain relatively localized
to the cortex and white matter (36 cases), higher in those that
invade deep cerebral nuclei unilaterally (17 cases), still higher
in those that cross the midline through the corpus callosum
(10 cases) and highest in those that invade into the contralateral
deep cerebral nuclei (15 cases). Matsukado et al. (1961) esti-
mated that the 36 relatively localized cases could have been
cured by radical surgery but Jelsma and Bucy (1967) failed
to cure any even with extensive resection approaching hemi-
spherectomy. This ﬁts with our conclusion that submicroscopic
invasion had taken place.
Although many attempts (radical resection and radiation ther-
apy) have been made to suggest that a boundary exists, gliomas
are typically diffuse with no clear boundary deﬁning the interface
between pathological and normal tissue. In this article, we demon-
strate that this behaviour is well modelled by a diffusion-based
motility process. Elsewhere we demonstrate this type of models
use in also predicting in vitro behaviour of glioma cell invasion
(Swanson, submitted).
Unlike real patients with real gliomas, virtual patients with
virtual gliomas can be analyzed by allowing any particular factor
to vary while keeping all the other determining factors constant.
Such isolation techniques, of course, require a mathematical model
that has sufﬁcient complexity to contain a realistic number of vari-
ables. The recent availability of simulated MRIs, with proportions
of grey and white matter accurately indicated, permitted the devel-
opment of this model which is sufﬁciently complex to allow
different diffusion rates in grey and white matter (e.g. a ﬁve-fold
increase in diffusion or migration in white matter) as well as to
prevent spread across sulci.
The model we have developed is a simple one focusing on two
key elements, namely diffusion and growth. Other variables can
and should be introduced into the model as their relative impor-
tance is discovered. These variables could range from
implications regarding the interaction of normal brain tissue with
malignant tissue to effectiveness of angiogenic vessels in providing
nutrients to the malignant tissue. Elsewhere, aspects concerning the
effect of tumour cell supopulations with different migration and
proliferation rates have been considered by Tracqui et al. (1995)
and Swanson (1999).
Previous studies have shown how to determine estimates for the
key parameters of our model from patient scans (Tracqui et al,
1995; Burgess et al, 1997; Swanson, 1999). With these estimates
the present model can be predictive as to where the tumour is
likely to grow in real time. Assuming that classical clinical neuroa-
natomy related to ‘eloquent’ sites applies to brain tumours as well
as strokes, we need to know the concentration of tumour cells in
any particular site necessary to produce symptoms and/or death.
Also, assuming that most gliomas swell, showing mass effect as
tumours, we will probably have to apply topological mathematical
formulations allowing the virtual brain to accommodate the swel-
lings and distortions visible in the real brain. Even without these,
however, what seems clear from these theoretical studies of virtual
gliomas is that current imaging techniques are woefully inadequate
for deﬁnitive decisions as to what constitutes the optimal treatment
for patients with gliomas.
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